Current Status
Not Enrolled
Price
Free
Get Started

Program Director

Khalid Al Rasadi, MD

Program Director

Raul D Santos, MD, MSc, PhD

2020 Middle East Summit on Residual Cardiovascular Risk

Cardiovascular diseases remain the #1 cause of death and disability globally and are on the rise in developing regions of the world. Despite advances in the control of the classic risk factors like lowering LDL-Cholesterol and efforts to manage contributing disease factors such as diabetes, obesity and hypertension, patient risk for developing ASCVD can still remain high. This course was designed to educate on the complete examination and clinical approaches to the treatment of residual risk (RR) factors that may persist and ultimately continue to drive the patient’s potential for cardiovascular events.

The IAS is pleased to present thirteen (13) recordings from the live accredited sessions presented at the 2020 Middle East Residual Risk Cardiovascular Summit held in Dubai on February 21-22, 2020. This comprehensive educational event was designed for medical professionals in the clinical setting.

The IAS is very grateful to Biologix FzCo for supporting the 2020 Middle East Residual Risk Cardiovascular Summit through an unrestricted educational grant. We also thank all the speakers and participants for sharing their experience and for helping IAS to develop this global faculty of experts featured in the presentations.

Pre-activity information

Not available

Video 14: Drug Therapy of High Blood Pressure (Release date August 23)

See more...

Not available

Video 13: Inflammation and Residual Risk (Release date August 23)

See more...

Not available

Video 12: LP(a) and Residual Risk (Release date August 23)

See more...

Not available

Video 11: New Triglycerides Reducing Drug Therapy (Release date August 23)

See more...

Not available

Video 10: Triglycerides and Residual Risk (Release date August 23)

See more...

Not available

Video 9: Residual Risk in Obesity and Diabetes (Release date July 26)

See more...

Not available

Video 8: Familial Hypercholesterolemia (Release date July 26)

See more...

Not available

Video 7: Drugs that can Supplement Statins (Release date July 26)

See more...

Not available

Video 6: The Art of Using Statin Therapy (Release date June 28)

See more...

Not available

Video 5: Clinical Trials of Statins (Release date June 28)

See more...

Not available

Video 4: Lipoprotein Targets of Therapy (Release date June 28)

See more...

Not available

Video 3: Diet and Heart Disease Prevention

See more...

Not available

Video 1: Preventing Death and Disability from Atherosclerosis

See more...

Not available

Video 2: Risk Factors-Origin and Development

See more...

Not available

Dextran Sulphate Lipoprotein Apheresis in FH and Beyond – Tiziana Sampietro, Italy

See more...

Not available

Clinical Case 3: Familial Hypercholesterolemia Homozygous Null Mutations – Zuhier Awan, KSA

See more...

Not available

Kuwait Audience Participant Survey

See more...

Not available

Clinical Case 4: Treatment of Type II Familial Hypercholesterolemia by Portacaval Anastomisis: A Case Report – Faouzi Maatouk, Tunisia

See more...

Not available

Clinical Case 3: PCSK-9 Inhibitor Resistance: Case Report – Noor Al Rajhi, Kuwait

See more...

« » page 1 / 6